日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of JAK1/2 inhibition in murine myeloproliferative neoplasms is not mediated by targeting oncogenic signaling

JAK1/2抑制剂在小鼠骨髓增生性肿瘤中的疗效并非通过靶向致癌信号通路介导。

Gorantla, Sivahari Prasad; Rassner, Michael; Crossley, Kirstyn Anne; Müller, Tony Andreas; Poggio, Teresa; Khaja Saleem, Shifa; Kleinfelder, Helen; Gambheer, Sudheer Madan Mohan; Endres, Cornelia; Schaberg, Sabina; Schmidt, Dominik; Prince, Gerin; Gonzalez-Menendez, Irene; Bentrop, Detlef; Trittler, Rainer; Rylova, Svetlana; Pfeifer, Dietmar; Andrieux, Geoffroy; Quintanilla-Martinez, Leticia; Illert, Anna Lena; von Bubnoff, Nikolas; Zeiser, Robert; Duyster, Justus

Ruxolitinib mediated paradoxical JAK2 hyperphosphorylation is due to the protection of activation loop tyrosines from phosphatases.

鲁索替尼介导的 JAK2 反常过度磷酸化是由于激活环酪氨酸免受磷酸酶的侵害所致

Gorantla Sivahari P, Oelschläger Lorenz, Prince Gerin, Osius Jasmin, Kolluri Suresh Babu, Maluje Yamil, Fähnrich Anke, Ernst Nancy, Barbosa Gulde Alanis, Ludwig Ralf Joachim, Gemoll Timo, Fliedner Stephanie, Walter Wencke, Haferlach Torsten, Gebauer Niklas, Busch Hauke, Duyster Justus, von Bubnoff Nikolas